Friday, 17 September 2021

A Review on the Management of Insulin Resistance | Chapter 13 | New Frontiers in Medicine and Medical Research Vol. 15

Introduction: Interventions for weight loss and relapse prevention have had mixed results. Furthermore, comorbidities such as type 2 diabetes, hypertension, hypercholesterolemia, hypertriglyceridemia, and gout have been treated as separate diseases until now, despite accumulating evidence that these morbidities are the result of a malfunctioning metabolism caused by insulin resistance.

The goal of this study is to gather evidence that treating obesity with weight loss lowers comorbidities and improves quality of life.

Obesity and its comorbidities require a comprehensive approach to treatment. It's possible to accomplish it in primary care. A low carbohydrate diet and exercise should be widely acknowledged as the two key parts of treatment that contribute to the desired result: significant weight loss and reduction of comorbidities, as evidenced by improved blood parameters and improved quality of life. Dietitians, with the help of psychologists, physiotherapists, and fitness trainers, can play a significant role in diet management due to the diet's intricacy. Diet and lifestyle play an essential impact in health, and family physicians and nurse practitioners should be aware of this. Medication is not the ideal treatment for insulin resistance and should be avoided as much as possible.

Conclusions: Health professionals can influence the prevalence and implications of obesity and its comorbidities by identifying and treating insulin resistance in primary care, lowering health care costs significantly. Fasting insulin levels are the best way to diagnose IR. Additional tools include measuring waist circumference and calculating BMI. Weight loss should be prioritised by management, which should include a low-carbohydrate diet with adequate fat, protein, vitamins, and minerals. Exercise is an important aspect of relapse prevention and management. Insulin-resistant people may be able to regain their health by following these guidelines. They will always be insulin resistant to some level, and they will be unable to consume the typical amounts of carbs recommended in general dietary guidelines.


Author (S) Details


E. Govers
President of KDOO, the Netherlands; vice-chair of ESDN Obesity of the European Federation of Associations of Dietitians (EFAD),Germany.


E. Slof
EetOké, dietitian, member of KDOO Advisory Board, The Netherlands.


H. Verkoelen
Prima-Vita, dietitian and diabeteic nurse, KDOO Board, The Netherlands.


N. M. Ten Hoor-Aukema
Bon Appetit Dietitians, The Netherlands.


View Book :- https://stm.bookpi.org/NFMMR-V15/article/view/3873




No comments:

Post a Comment